Table 3 Cluster-level differences in FA and related metrics after 5 years of medication compared to baseline for the medication-resistant AVH group.
 | Baseline | Five years later | P |
---|---|---|---|
n | n = 48 | n = 48 |  |
Mean FA of clusters with significant group differences in FA | 0.32 ± 0.01 | 0.54 ± 0.02 | <0.001a |
Mean AD of clusters with significant group differences in FA | 0.75 ± 0.01 (10−3) | 0.88 ± 0.02 (10−3) | <0.001a |
Mean RD of clusters with significant group differences in FA | 0.63 ± 0.03 (10−3) | 0.51 ± 0.05(10−3) | <0.001a |
Mean MD of clusters with significant group differences in FA | 0.60 ± 0.04 (10−3) | 0.63 ± 0.03 (10−3) | <0.001a |